ISABEL MIKE: Open Payments
NPI 1447800388 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,069 in 49 payments from 21 companies in 2025. Trend: 2023 $543 · 2024 $260 · 2025 $1,069
Food & beverage: $1,069
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $185 |
| TG Therapeutics, Inc. | 1 | $150 |
| Biogen, Inc. | 5 | $96 |
| Genentech USA, Inc. | 3 | $89 |
| Alexion Pharmaceuticals, Inc. | 3 | $68 |
| UCB, Inc. | 3 | $54 |
| Eisai Inc. | 2 | $51 |
| Tonix Medicines, Inc. | 3 | $49 |
| ARGENX US, INC. | 2 | $42 |
| Lilly USA, LLC | 2 | $39 |
Products named: BRIUMVI, BOTOX, TYSABRI, Ocrevus Zunovo, ULTOMIRIS, Nayzilam, Leqembi, ZEMBRACE SYMTOUCH.
Industry payments across AZ — which companies pay providers there.
